NCT00401128View on ClinicalTrials.gov

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Kidney Cancer
Interventions
DRUG

gemcitabine hydrochloride

DRUG

irinotecan hydrochloride

Trial Locations (1)

44106-5065

Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

The Cleveland Clinic

OTHER

NCT00401128 - Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter